We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
-14.52%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.28B
AUM Growth
-$544M
Cap. Flow
-$81.4M
Cap. Flow %
-3.57%
Top 10 Hldgs %
26.06%
Holding
266
New
15
Increased
63
Reduced
107
Closed
19

Top Buys

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$34.3M
2
KMX icon
CarMax
KMX
+$31.1M
3
FDC
First Data Corporation
FDC
+$26.6M
4
FDX icon
FedEx
FDX
+$17.7M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$12.9M

Top Sells

Rank Stock Value
1
WRK
WestRock Company
WRK
+$32.9M
2
JELD icon
JELD-WEN Holding
JELD
+$23.3M
3
CLR
CONTINENTAL RESOURCES INC.
CLR
+$22.3M
4
REI icon
Ring Energy
REI
+$15.5M
5
ZBH icon
Zimmer Biomet
ZBH
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 17.13%
2 Technology 17.04%
3 Industrials 13.43%
4 Financials 12.95%
5 Consumer Discretionary 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UGI icon
226
UGI
UGI
$8B
$208K 0.01%
3,893
– –
HES
227
DELISTED
Hess
HES
$207K 0.01%
5,100
– –
TRTX
228
TPG RE Finance Trust
TRTX
$666M
$207K 0.01%
+11,300
New +$221K
PGC icon
229
Peapack-Gladstone Financial
PGC
$822M
$206K 0.01%
8,171
– –
VOO icon
230
Vanguard S&P 500 ETF
VOO
$968B
$205K 0.01%
+890
New +$220K
PNC icon
231
PNC Financial Services
PNC
$100B
$203K 0.01%
1,740
– –
MACK
232
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$193K 0.01%
63,499
-32,292
-34% -$112K
DAIO icon
233
Data I/O
DAIO
$32M
$160K 0.01%
32,000
– –
ENLC
234
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$128K 0.01%
13,500
– –
RIBT
235
DELISTED
RiceBran Technologies
RIBT
$127K 0.01%
4,241
– –
RRC icon
236
Range Resources
RRC
$9.11B
$112K ﹤0.01%
11,750
– –
YTEN
237
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$97K ﹤0.01%
122
– –
APHA
238
DELISTED
Aphria Inc. Common Shares
APHA
$94K ﹤0.01%
+16,500
New +$130K
VRML
239
DELISTED
Vermillion, Inc.
VRML
$86K ﹤0.01%
286,000
-50,000
-15% -$25.5K
CELGZ
240
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$85K ﹤0.01%
188,183
-31,100
-14% -$28.4K
AVEO
241
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$56K ﹤0.01%
3,500
+500
+17% +$11K
TEUM
242
DELISTED
Pareteum Corporation
TEUM
$34K ﹤0.01%
20,408
-153,257
-88% -$318K
IZEA icon
243
IZEA Worldwide
IZEA
$59.5M
$33K ﹤0.01%
8,418
-843
-9% -$4.89K
ROX
244
DELISTED
Castle Brands, Inc.
ROX
$23K ﹤0.01%
+27,500
New +$25.3K
EMMA
245
DELISTED
Emmaus Life Sciences, Inc. Common Stock
EMMA
$15K ﹤0.01%
3,333
– –
KOPN icon
246
Kopin
KOPN
$663M
$11K ﹤0.01%
11,000
– –
MYNDW
247
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$2K ﹤0.01%
20,000
– –
AGIO icon
248
Agios Pharmaceuticals
AGIO
$2.16B
– –
-48,485
Closed -$3.74M
BLK icon
249
Blackrock
BLK
$164B
– –
-1,495
Closed -$705K
C icon
250
Citigroup
C
$222B
– –
-79,970
Closed -$5.74M
7 8 9
10
11

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Cannell & Co held 266 positions worth $2.28B, down 19% from $2.83B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cannell & Co withdrew a net $81.4M in Q4 2018, closing 19 positions and reducing 107 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, Cannell & Co opened a new position in First Data Corporation worth $23.1M.

  • Cannell & Co's largest Q4 2018 buy was First Data Corporation: 1,363,150 shares worth $23.1M.
  • Cannell & Co added most to Tiffany & Co. in Q4 2018, an estimated $34.3M increase.
  • Cannell & Co's biggest Q4 2018 reduction was WestRock Company, cutting an estimated $32.9M.
  • Cannell & Co fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $12.2M.
  • Cannell & Co's ten largest holdings make up 26% of its $2.28B portfolio in Q4 2018.
  • Cannell & Co opened 15 new positions and closed 19 in Q4 2018.
  • Cannell & Co's portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Cannell & Co's 13F filing for Q4 2018, filed 11 Feb 2019.